SCIENTURE HOLDINGS, INC. Repayments of Other Long-term Debt
SCIENTURE HOLDINGS, INC. (SCNX) reported Repayments of Other Long-term Debt of $432.69 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherLongTermDebt · last filed 2018-03-02
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for the quarter ending 2017-12-31 was $42.73K, a 16.17% decline year-over-year.
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for the quarter ending 2017-09-30 was $46.65K, a 1141.35% increase year-over-year.
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for the quarter ending 2016-12-31 was $50.98K.
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for the quarter ending 2016-09-30 was $3.76K.
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for fiscal 2017 was $432.69K, a 690.51% increase from fiscal 2016.
- SCIENTURE HOLDINGS, INC. repayments of other long-term debt for fiscal 2016 was $54.73K.
| Period end | Repayments of Other Long-term Debt 3 month | Repayments of Other Long-term Debt 6 month | Repayments of Other Long-term Debt 9 month | Repayments of Other Long-term Debt 12 month |
|---|---|---|---|---|
| 2017-12-31 | $42.73K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $89.38K derived: sum of 2 quarters · filed 2018-03-02 | $432.69K 10-K · filed 2018-03-02 | |
| 2017-09-30 | $46.65K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $389.95K 10-Q · filed 2017-11-07 | ||
| 2017-06-30 | $343.30K 10-Q · filed 2017-08-04 | |||
| 2016-12-31 | $50.98K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-02 | $54.73K derived: sum of 2 quarters · filed 2018-03-02 | $54.73K 10-K · filed 2018-03-02 | |
| 2016-09-30 | $3.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $3.76K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |